Tumor necrosis factor α as a master regulator of inflammation in Erdheim-Chester disease: Rationale for the treatment of patients with infliximab

Lorenzo Dagna; Angelo Corti; Silvia Langheim; Barbara Guglielmi; Francesco De Cobelli; Claudio Doglioni; Gabriele Fragasso; Maria Grazia Sabbadini; Marina Ferrarini

doi:10.1200/JCO.2012.41.9911

Tumor necrosis factor α as a master regulator of inflammation in Erdheim-Chester disease: Rationale for the treatment of patients with infliximab

Lorenzo Dagna, Angelo Corti, Silvia Langheim, Barbara Guglielmi, Francesco De Cobelli, Claudio Doglioni, Gabriele Fragasso, Maria Grazia Sabbadini, Marina Ferrarini

IRCCS Ospedale San Raffaele

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Journal of Clinical Oncology
Volume	30
Issue number	28
DOIs	https://doi.org/10.1200/JCO.2012.41.9911
Publication status	Published - Oct 1 2012

ASJC Scopus subject areas

Cancer Research
Oncology

Access to Document

10.1200/JCO.2012.41.9911

Cite this

Tumor necrosis factor α as a master regulator of inflammation in Erdheim-Chester disease : Rationale for the treatment of patients with infliximab. / Dagna, Lorenzo ; Corti, Angelo; Langheim, Silvia; Guglielmi, Barbara; De Cobelli, Francesco ; Doglioni, Claudio ; Fragasso, Gabriele; Sabbadini, Maria Grazia; Ferrarini, Marina.

In: Journal of Clinical Oncology, Vol. 30, No. 28, 01.10.2012.

Research output: Contribution to journal › Article › peer-review

Dagna, Lorenzo ; Corti, Angelo ; Langheim, Silvia ; Guglielmi, Barbara ; De Cobelli, Francesco ; Doglioni, Claudio ; Fragasso, Gabriele ; Sabbadini, Maria Grazia ; Ferrarini, Marina. / Tumor necrosis factor α as a master regulator of inflammation in Erdheim-Chester disease : Rationale for the treatment of patients with infliximab. In: Journal of Clinical Oncology. 2012 ; Vol. 30, No. 28.

@article{1e978aad4a2f4887b1e994bb6f5ffa44,

title = "Tumor necrosis factor α as a master regulator of inflammation in Erdheim-Chester disease: Rationale for the treatment of patients with infliximab",

author = "Lorenzo Dagna and Angelo Corti and Silvia Langheim and Barbara Guglielmi and {De Cobelli}, Francesco and Claudio Doglioni and Gabriele Fragasso and Sabbadini, {Maria Grazia} and Marina Ferrarini",

year = "2012",

month = oct,

day = "1",

doi = "10.1200/JCO.2012.41.9911",

language = "English",

volume = "30",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "28",

}

TY - JOUR

T1 - Tumor necrosis factor α as a master regulator of inflammation in Erdheim-Chester disease

T2 - Rationale for the treatment of patients with infliximab

AU - Dagna, Lorenzo

AU - Corti, Angelo

AU - Langheim, Silvia

AU - Guglielmi, Barbara

AU - De Cobelli, Francesco

AU - Doglioni, Claudio

AU - Fragasso, Gabriele

AU - Sabbadini, Maria Grazia

AU - Ferrarini, Marina

PY - 2012/10/1

Y1 - 2012/10/1

UR - http://www.scopus.com/inward/record.url?scp=84867083505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867083505&partnerID=8YFLogxK

U2 - 10.1200/JCO.2012.41.9911

DO - 10.1200/JCO.2012.41.9911

M3 - Article

C2 - 22869874

AN - SCOPUS:84867083505

VL - 30

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 28

ER -